Global Nasal Drug Delivery Technology Market Outlook 2021

Publisher Name :
Date: 19-Nov-2020
No. of pages: 123
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Nasal Drug Delivery Technology market is segmented into

- Pressurized Type

- Non-pressurized Type

Segment by Application

- Nasal Congestion

- Rhinitis

- Asthma

- Other

Global Nasal Drug Delivery Technology Market: Regional Analysis

The Nasal Drug Delivery Technology market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Nasal Drug Delivery Technology market report are:

- North America

- U.S.

- Canada

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

- Latin America

- Mexico

- Brazil

- Argentina

- Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Nasal Drug Delivery Technology Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Nasal Drug Delivery Technology market include:

- 3M United States

- Aegis Therapeutics LLC

- Aptargroup, Inc.

- Becton, Dickinson and Company

- BF Ascher & Company, Inc.

- Cadila Pharmaceuticals Ltd

- Dickinson and Company

- Douglas Pharmaceuticals Ltd

- ENT Technologies Pty. Ltd

- Glaxosmithkline PLC

- Johnson & Johnson

- Merck & Co., Inc.

- Novartis AG

- OptiNose, Inc

- PendoPharm, Inc

- Pfizer, Inc

- Promius Pharma, LLC

- Shin Nippon Biomedical Laboratories

Global Nasal Drug Delivery Technology Market Outlook 2021

Table of Contents
1 Nasal Drug Delivery Technology Market Overview
1.1 Product Overview and Scope of Nasal Drug Delivery Technology
1.2 Nasal Drug Delivery Technology Segment by Type
1.2.1 Global Nasal Drug Delivery Technology Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Pressurized Type
1.2.3 Non-pressurized Type
1.3 Nasal Drug Delivery Technology Segment by Application
1.3.1 Nasal Drug Delivery Technology Sales Comparison by Application: (2020-2026)
1.3.2 Nasal Congestion
1.3.3 Rhinitis
1.3.4 Asthma
1.3.5 Other
1.4 Global Nasal Drug Delivery Technology Market Size Estimates and Forecasts
1.4.1 Global Nasal Drug Delivery Technology Revenue 2015-2026
1.4.2 Global Nasal Drug Delivery Technology Sales 2015-2026
1.4.3 Nasal Drug Delivery Technology Market Size by Region: 2020 Versus 2026
2 Global Nasal Drug Delivery Technology Market Competition by Manufacturers
2.1 Global Nasal Drug Delivery Technology Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nasal Drug Delivery Technology Revenue Share by Manufacturers (2015-2020)
2.3 Global Nasal Drug Delivery Technology Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nasal Drug Delivery Technology Manufacturing Sites, Area Served, Product Type
2.5 Nasal Drug Delivery Technology Market Competitive Situation and Trends
2.5.1 Nasal Drug Delivery Technology Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nasal Drug Delivery Technology Players (Opinion Leaders)
3 Nasal Drug Delivery Technology Retrospective Market Scenario by Region
3.1 Global Nasal Drug Delivery Technology Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nasal Drug Delivery Technology Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nasal Drug Delivery Technology Market Facts & Figures by Country
3.3.1 North America Nasal Drug Delivery Technology Sales by Country
3.3.2 North America Nasal Drug Delivery Technology Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nasal Drug Delivery Technology Market Facts & Figures by Country
3.4.1 Europe Nasal Drug Delivery Technology Sales by Country
3.4.2 Europe Nasal Drug Delivery Technology Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nasal Drug Delivery Technology Market Facts & Figures by Region
3.5.1 Asia Pacific Nasal Drug Delivery Technology Sales by Region
3.5.2 Asia Pacific Nasal Drug Delivery Technology Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nasal Drug Delivery Technology Market Facts & Figures by Country
3.6.1 Latin America Nasal Drug Delivery Technology Sales by Country
3.6.2 Latin America Nasal Drug Delivery Technology Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nasal Drug Delivery Technology Market Facts & Figures by Country
3.7.1 Middle East and Africa Nasal Drug Delivery Technology Sales by Country
3.7.2 Middle East and Africa Nasal Drug Delivery Technology Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nasal Drug Delivery Technology Historic Market Analysis by Type
4.1 Global Nasal Drug Delivery Technology Sales Market Share by Type (2015-2020)
4.2 Global Nasal Drug Delivery Technology Revenue Market Share by Type (2015-2020)
4.3 Global Nasal Drug Delivery Technology Price Market Share by Type (2015-2020)
4.4 Global Nasal Drug Delivery Technology Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Nasal Drug Delivery Technology Historic Market Analysis by Application
5.1 Global Nasal Drug Delivery Technology Sales Market Share by Application (2015-2020)
5.2 Global Nasal Drug Delivery Technology Revenue Market Share by Application (2015-2020)
5.3 Global Nasal Drug Delivery Technology Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nasal Drug Delivery Technology Business
6.1 3M United States
6.1.1 Corporation Information
6.1.2 3M United States Description, Business Overview
6.1.3 3M United States Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.1.4 3M United States Products Offered
6.1.5 3M United States Recent Development
6.2 Aegis Therapeutics LLC
6.2.1 Aegis Therapeutics LLC Corporation Information
6.2.2 Aegis Therapeutics LLC Description, Business Overview
6.2.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Aegis Therapeutics LLC Products Offered
6.2.5 Aegis Therapeutics LLC Recent Development
6.3 Aptargroup, Inc.
6.3.1 Aptargroup, Inc. Corporation Information
6.3.2 Aptargroup, Inc. Description, Business Overview
6.3.3 Aptargroup, Inc. Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Aptargroup, Inc. Products Offered
6.3.5 Aptargroup, Inc. Recent Development
6.4 Becton, Dickinson and Company
6.4.1 Becton, Dickinson and Company Corporation Information
6.4.2 Becton, Dickinson and Company Description, Business Overview
6.4.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Becton, Dickinson and Company Products Offered
6.4.5 Becton, Dickinson and Company Recent Development
6.5 BF Ascher & Company, Inc.
6.5.1 BF Ascher & Company, Inc. Corporation Information
6.5.2 BF Ascher & Company, Inc. Description, Business Overview
6.5.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.5.4 BF Ascher & Company, Inc. Products Offered
6.5.5 BF Ascher & Company, Inc. Recent Development
6.6 Cadila Pharmaceuticals Ltd
6.6.1 Cadila Pharmaceuticals Ltd Corporation Information
6.6.2 Cadila Pharmaceuticals Ltd Description, Business Overview
6.6.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Cadila Pharmaceuticals Ltd Products Offered
6.6.5 Cadila Pharmaceuticals Ltd Recent Development
6.7 Dickinson and Company
6.6.1 Dickinson and Company Corporation Information
6.6.2 Dickinson and Company Description, Business Overview
6.6.3 Dickinson and Company Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Dickinson and Company Products Offered
6.7.5 Dickinson and Company Recent Development
6.8 Douglas Pharmaceuticals Ltd
6.8.1 Douglas Pharmaceuticals Ltd Corporation Information
6.8.2 Douglas Pharmaceuticals Ltd Description, Business Overview
6.8.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Douglas Pharmaceuticals Ltd Products Offered
6.8.5 Douglas Pharmaceuticals Ltd Recent Development
6.9 ENT Technologies Pty. Ltd
6.9.1 ENT Technologies Pty. Ltd Corporation Information
6.9.2 ENT Technologies Pty. Ltd Description, Business Overview
6.9.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.9.4 ENT Technologies Pty. Ltd Products Offered
6.9.5 ENT Technologies Pty. Ltd Recent Development
6.10 Glaxosmithkline PLC
6.10.1 Glaxosmithkline PLC Corporation Information
6.10.2 Glaxosmithkline PLC Description, Business Overview
6.10.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Glaxosmithkline PLC Products Offered
6.10.5 Glaxosmithkline PLC Recent Development
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Nasal Drug Delivery Technology Description, Business Overview
6.11.3 Johnson & Johnson Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Johnson & Johnson Products Offered
6.11.5 Johnson & Johnson Recent Development
6.12 Merck & Co., Inc.
6.12.1 Merck & Co., Inc. Corporation Information
6.12.2 Merck & Co., Inc. Nasal Drug Delivery Technology Description, Business Overview
6.12.3 Merck & Co., Inc. Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Merck & Co., Inc. Products Offered
6.12.5 Merck & Co., Inc. Recent Development
6.13 Novartis AG
6.13.1 Novartis AG Corporation Information
6.13.2 Novartis AG Nasal Drug Delivery Technology Description, Business Overview
6.13.3 Novartis AG Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Novartis AG Products Offered
6.13.5 Novartis AG Recent Development
6.14 OptiNose, Inc
6.14.1 OptiNose, Inc Corporation Information
6.14.2 OptiNose, Inc Nasal Drug Delivery Technology Description, Business Overview
6.14.3 OptiNose, Inc Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.14.4 OptiNose, Inc Products Offered
6.14.5 OptiNose, Inc Recent Development
6.15 PendoPharm, Inc
6.15.1 PendoPharm, Inc Corporation Information
6.15.2 PendoPharm, Inc Nasal Drug Delivery Technology Description, Business Overview
6.15.3 PendoPharm, Inc Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.15.4 PendoPharm, Inc Products Offered
6.15.5 PendoPharm, Inc Recent Development
6.16 Pfizer, Inc
6.16.1 Pfizer, Inc Corporation Information
6.16.2 Pfizer, Inc Nasal Drug Delivery Technology Description, Business Overview
6.16.3 Pfizer, Inc Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Pfizer, Inc Products Offered
6.16.5 Pfizer, Inc Recent Development
6.17 Promius Pharma, LLC
6.17.1 Promius Pharma, LLC Corporation Information
6.17.2 Promius Pharma, LLC Nasal Drug Delivery Technology Description, Business Overview
6.17.3 Promius Pharma, LLC Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Promius Pharma, LLC Products Offered
6.17.5 Promius Pharma, LLC Recent Development
6.18 Shin Nippon Biomedical Laboratories
6.18.1 Shin Nippon Biomedical Laboratories Corporation Information
6.18.2 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Description, Business Overview
6.18.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Shin Nippon Biomedical Laboratories Products Offered
6.18.5 Shin Nippon Biomedical Laboratories Recent Development
7 Nasal Drug Delivery Technology Manufacturing Cost Analysis
7.1 Nasal Drug Delivery Technology Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nasal Drug Delivery Technology
7.4 Nasal Drug Delivery Technology Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nasal Drug Delivery Technology Distributors List
8.3 Nasal Drug Delivery Technology Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nasal Drug Delivery Technology Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nasal Drug Delivery Technology by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nasal Drug Delivery Technology by Type (2021-2026)
10.2 Nasal Drug Delivery Technology Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nasal Drug Delivery Technology by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nasal Drug Delivery Technology by Application (2021-2026)
10.3 Nasal Drug Delivery Technology Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nasal Drug Delivery Technology by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nasal Drug Delivery Technology by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Nasal Drug Delivery Technology Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nasal Drug Delivery Technology Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Nasal Drug Delivery Technology Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Nasal Drug Delivery Technology Manufacturers Covered in This Study
Table 5. Global Nasal Drug Delivery Technology Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Nasal Drug Delivery Technology Sales Share by Manufacturers (2015-2020)
Table 7. Global Nasal Drug Delivery Technology Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Nasal Drug Delivery Technology Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Nasal Drug Delivery Technology Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Nasal Drug Delivery Technology Sales Sites and Area Served
Table 11. Manufacturers Nasal Drug Delivery Technology Product Types
Table 12. Global Nasal Drug Delivery Technology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nasal Drug Delivery Technology by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Drug Delivery Technology as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Nasal Drug Delivery Technology Players
Table 16. Global Nasal Drug Delivery Technology Sales (K Units) by Region (2015-2020)
Table 17. Global Nasal Drug Delivery Technology Sales Market Share by Region (2015-2020)
Table 18. Global Nasal Drug Delivery Technology Revenue (Million US$) by Region (2015-2020)
Table 19. Global Nasal Drug Delivery Technology Revenue Market Share by Region (2015-2020)
Table 20. North America Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 21. North America Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 22. North America Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 24. Europe Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 25. Europe Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 26. Europe Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Nasal Drug Delivery Technology Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Nasal Drug Delivery Technology Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Nasal Drug Delivery Technology Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Nasal Drug Delivery Technology Revenue Market Share by Region (2015-2020)
Table 32. Latin America Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 33. Latin America Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 34. Latin America Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Nasal Drug Delivery Technology Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Nasal Drug Delivery Technology Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Nasal Drug Delivery Technology Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Nasal Drug Delivery Technology Revenue Market Share by Country (2015-2020)
Table 40. Global Nasal Drug Delivery Technology Sales (K Units) by Type (2015-2020)
Table 41. Global Nasal Drug Delivery Technology Sales Share by Type (2015-2020)
Table 42. Global Nasal Drug Delivery Technology Revenue (Million US$) by Type (2015-2020)
Table 43. Global Nasal Drug Delivery Technology Revenue Share by Type (2015-2020)
Table 44. Global Nasal Drug Delivery Technology Price (USD/Unit) by Type (2015-2020)
Table 45. Global Nasal Drug Delivery Technology Sales (K Units) by Application (2015-2020)
Table 46. Global Nasal Drug Delivery Technology Sales Market Share by Application (2015-2020)
Table 47. Global Nasal Drug Delivery Technology Sales Growth Rate by Application (2015-2020)
Table 48. 3M United States Corporation Information
Table 49. 3M United States Description and Business Overview
Table 50. 3M United States Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. 3M United States Main Product
Table 52. 3M United States Recent Development
Table 53. Aegis Therapeutics LLC Corporation Information
Table 54. Aegis Therapeutics LLC Description and Business Overview
Table 55. Aegis Therapeutics LLC Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Aegis Therapeutics LLC Main Product
Table 57. Aegis Therapeutics LLC Recent Development
Table 58. Aptargroup, Inc. Corporation Information
Table 59. Aptargroup, Inc. Description and Business Overview
Table 60. Aptargroup, Inc. Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Aptargroup, Inc. Main Product
Table 62. Aptargroup, Inc. Recent Development
Table 63. Becton, Dickinson and Company Corporation Information
Table 64. Becton, Dickinson and Company Description and Business Overview
Table 65. Becton, Dickinson and Company Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Becton, Dickinson and Company Main Product
Table 67. Becton, Dickinson and Company Recent Development
Table 68. BF Ascher & Company, Inc. Corporation Information
Table 69. BF Ascher & Company, Inc. Description and Business Overview
Table 70. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. BF Ascher & Company, Inc. Main Product
Table 72. BF Ascher & Company, Inc. Recent Development
Table 73. Cadila Pharmaceuticals Ltd Corporation Information
Table 74. Cadila Pharmaceuticals Ltd Description and Business Overview
Table 75. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Cadila Pharmaceuticals Ltd Main Product
Table 77. Cadila Pharmaceuticals Ltd Recent Development
Table 78. Dickinson and Company Corporation Information
Table 79. Dickinson and Company Description and Business Overview
Table 80. Dickinson and Company Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Dickinson and Company Main Product
Table 82. Dickinson and Company Recent Development
Table 83. Douglas Pharmaceuticals Ltd Corporation Information
Table 84. Douglas Pharmaceuticals Ltd Description and Business Overview
Table 85. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Douglas Pharmaceuticals Ltd Main Product
Table 87. Douglas Pharmaceuticals Ltd Recent Development
Table 88. ENT Technologies Pty. Ltd Corporation Information
Table 89. ENT Technologies Pty. Ltd Description and Business Overview
Table 90. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. ENT Technologies Pty. Ltd Main Product
Table 92. ENT Technologies Pty. Ltd Recent Development
Table 93. Glaxosmithkline PLC Corporation Information
Table 94. Glaxosmithkline PLC Description and Business Overview
Table 95. Glaxosmithkline PLC Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Glaxosmithkline PLC Main Product
Table 97. Glaxosmithkline PLC Recent Development
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Business Overview
Table 100. Johnson & Johnson Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Johnson & Johnson Main Product
Table 102. Johnson & Johnson Recent Development
Table 103. Merck & Co., Inc. Corporation Information
Table 104. Merck & Co., Inc. Description and Business Overview
Table 105. Merck & Co., Inc. Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Merck & Co., Inc. Main Product
Table 107. Merck & Co., Inc. Recent Development
Table 108. Novartis AG Corporation Information
Table 109. Novartis AG Description and Business Overview
Table 110. Novartis AG Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Novartis AG Main Product
Table 112. Novartis AG Recent Development
Table 113. OptiNose, Inc Corporation Information
Table 114. OptiNose, Inc Description and Business Overview
Table 115. OptiNose, Inc Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. OptiNose, Inc Main Product
Table 117. OptiNose, Inc Recent Development
Table 118. PendoPharm, Inc Corporation Information
Table 119. PendoPharm, Inc Description and Business Overview
Table 120. PendoPharm, Inc Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. PendoPharm, Inc Main Product
Table 122. PendoPharm, Inc Recent Development
Table 123. Pfizer, Inc Corporation Information
Table 124. Pfizer, Inc Description and Business Overview
Table 125. Pfizer, Inc Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Pfizer, Inc Main Product
Table 127. Pfizer, Inc Recent Development
Table 128. Promius Pharma, LLC Corporation Information
Table 129. Promius Pharma, LLC Description and Business Overview
Table 130. Promius Pharma, LLC Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Promius Pharma, LLC Main Product
Table 132. Promius Pharma, LLC Recent Development
Table 133. Shin Nippon Biomedical Laboratories Corporation Information
Table 134. Shin Nippon Biomedical Laboratories Description and Business Overview
Table 135. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Shin Nippon Biomedical Laboratories Main Product
Table 137. Shin Nippon Biomedical Laboratories Recent Development
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Nasal Drug Delivery Technology Distributors List
Table 141. Nasal Drug Delivery Technology Customers List
Table 142. Nasal Drug Delivery Technology Market Trends
Table 143. Nasal Drug Delivery Technology Opportunities and Drivers
Table 144. Nasal Drug Delivery Technology Market Challenges
Table 145. Global Nasal Drug Delivery Technology Sales (K Units) Forecast by Type (2021-2026)
Table 146. Global Nasal Drug Delivery Technology Sales Market Share Forecast by Type (2021-2026)
Table 147. Global Nasal Drug Delivery Technology Revenue (Million US$) Forecast by Type (2021-2026)
Table 148. Global Nasal Drug Delivery Technology Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 149. Global Nasal Drug Delivery Technology Sales (K Units) Forecast by Application (2021-2026)
Table 150. Global Nasal Drug Delivery Technology Revenue (Million US$) Forecast by Application (2021-2026)
Table 151. Global Nasal Drug Delivery Technology Sales (K Units) Forecast by Region (2021-2026)
Table 152. Global Nasal Drug Delivery Technology Sales Market Share Forecast by Region (2021-2026)
Table 153. Global Nasal Drug Delivery Technology Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Global Nasal Drug Delivery Technology Revenue Market Share Forecast by Region (2021-2026)
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Nasal Drug Delivery Technology
Figure 2. Global Nasal Drug Delivery Technology Sales Market Share by Type: 2020 VS 2026
Figure 3. Pressurized Type Product Picture
Figure 4. Non-pressurized Type Product Picture
Figure 5. Global Nasal Drug Delivery Technology Consumption Market Share by Application: 2020 VS 2026
Figure 6. Nasal Congestion
Figure 7. Rhinitis
Figure 8. Asthma
Figure 9. Other
Figure 10. Global Nasal Drug Delivery Technology Market Size 2015-2026 (US$ Million)
Figure 11. Global Nasal Drug Delivery Technology Sales Capacity (K Units) (2015-2026)
Figure 12. Global Nasal Drug Delivery Technology Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Nasal Drug Delivery Technology Sales Share by Manufacturers in 2020
Figure 14. Global Nasal Drug Delivery Technology Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nasal Drug Delivery Technology Revenue in 2019
Figure 16. Nasal Drug Delivery Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Nasal Drug Delivery Technology Sales Market Share by Region (2015-2020)
Figure 18. Global Nasal Drug Delivery Technology Sales Market Share by Region in 2019
Figure 19. Global Nasal Drug Delivery Technology Revenue Market Share by Region (2015-2020)
Figure 20. Global Nasal Drug Delivery Technology Revenue Market Share by Region in 2019
Figure 21. North America Nasal Drug Delivery Technology Sales Market Share by Country in 2019
Figure 22. North America Nasal Drug Delivery Technology Revenue Market Share by Country in 2019
Figure 23. U.S. Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Nasal Drug Delivery Technology Sales Market Share by Country in 2019
Figure 28. Europe Nasal Drug Delivery Technology Revenue Market Share by Country in 2019
Figure 29. Germany Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Nasal Drug Delivery Technology Sales Market Share by Region in 2019
Figure 40. Asia Pacific Nasal Drug Delivery Technology Revenue Market Share by Region in 2019
Figure 41. China Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Nasal Drug Delivery Technology Sales Market Share by Country in 2019
Figure 64. Latin America Nasal Drug Delivery Technology Revenue Market Share by Country in 2019
Figure 65. Mexico Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Nasal Drug Delivery Technology Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Nasal Drug Delivery Technology Revenue Market Share by Country in 2019
Figure 73. Turkey Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Nasal Drug Delivery Technology Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Nasal Drug Delivery Technology Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Nasal Drug Delivery Technology by Type (2015-2020)
Figure 80. Sales Market Share of Nasal Drug Delivery Technology by Type in 2020
Figure 81. Global Nasal Drug Delivery Technology Market Share by Price Range (2015-2020)
Figure 82. Revenue Market Share of Nasal Drug Delivery Technology by Type in 2019
Figure 83. Global Nasal Drug Delivery Technology Sales Growth by Type (2015-2020) (K Units)
Figure 84. Sales Market Share of Nasal Drug Delivery Technology by Application (2015-2020)
Figure 85. Sales Market Share of Nasal Drug Delivery Technology by Application in 2020
Figure
  • (Post-pandemic Era) - Global Vinpocetine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 93
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vinpocetine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regio......
  • (Post-pandemic Era) - Global Vinpocetine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vinpocetine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 85
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vaccine Adjuvants growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 109
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vaccine Adjuvants Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 109
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Saffron Extract Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 110
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 12-Apr-2021        Price: US 3160 Onwards        Pages: 98
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs